{
  "meta": {
    "title": {
      "ko": "ì˜¤ë¯¹ìŠ¤AI - AI ê¸°ë°˜ ì˜¤ë¯¹ìŠ¤ ë¶„ì„",
      "en": "OmixAI - AI-Powered Omics Analysis"
    }
  },
  "nav": {
    "services": { "ko": "ì„œë¹„ìŠ¤", "en": "Services" },
    "resources": { "ko": "ìë£Œì‹¤", "en": "Resources" },
    "about": { "ko": "íšŒì‚¬ ì†Œê°œ", "en": "About Us" },
    "contact": { "ko": "ë¬¸ì˜", "en": "Contact" },
    "cta": { "ko": "ë¬¸ì˜í•˜ê¸°", "en": "Contact Us" },
    "orderNow": { "ko": "ì£¼ë¬¸í•˜ê¸°", "en": "Order Now" }
  },
  "hero": {
    "title": {
      "ko": "ìƒëª…ì˜ ì§„ì •í•œ ì–¸ì–´ë¥¼ í•´ë…í•˜ë‹¤",
      "en": "Decoding the True Language of Life"
    },
    "subtitle": {
      "ko": "ìƒë¬¼í•™ì˜ ìˆ¨ê²¨ì§„ ì•”í˜¸ë¥¼ ë“œëŸ¬ë‚´ëŠ” ë¹ ë¥´ê³  ì •í™•í•œ í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤â€”ëª‡ ë‹¬ì´ ì•„ë‹Œ ëª‡ ì£¼ ë§Œì— ë…¼ë¬¸ ì¶œíŒ ê°€ëŠ¥í•œ ê²°ê³¼",
      "en": "Fast, accurate proteomics revealing biology's hidden codeâ€”publication-ready results in weeks, not months"
    },
    "description": {
      "ko": "í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤, ì§€ë…¸ë¯¹ìŠ¤ ë° ë©€í‹°ì˜¤ë¯¹ìŠ¤ í†µí•©ì„ ìœ„í•œ ê³ ê¸‰ AI ëª¨ë¸",
      "en": "Advanced AI models for proteomics, genomics, and multi-omics integration"
    },
    "cta": { "ko": "ë¬¸ì˜í•˜ê¸°", "en": "Contact Us" }
  },
  "services": {
    "title": { "ko": "ì„œë¹„ìŠ¤", "en": "Our Services" },
    "items": [
      { "icon": "ğŸ§«", "title": { "ko": "ì„¸í¬ì£¼", "en": "Cell Lines" }, "slug": "cell-lines" },
      { "icon": "ğŸ”¬", "title": { "ko": "ì˜¤ê°€ë…¸ì´ë“œ", "en": "Organoid" }, "slug": "organoid" },
      { "icon": "ğŸ§ª", "title": { "ko": "FFPE", "en": "FFPE" }, "slug": "ffpe" },
      { "icon": "â„ï¸", "title": { "ko": "ë™ê²° ì¡°ì§", "en": "Frozen Tissue" }, "slug": "frozen-tissue" },
      { "icon": "ğŸ’‰", "title": { "ko": "í”Œë¼ì¦ˆë§ˆ", "en": "Plasma" }, "slug": "plasma" },
      { "icon": "ğŸ©¸", "title": { "ko": "í˜ˆì²­", "en": "Serum" }, "slug": "serum" },
      { "icon": "ğŸ§ ", "title": { "ko": "ë‡Œì²™ìˆ˜ì•¡", "en": "CSF" }, "slug": "csf" },
      { "icon": "ğŸ§¬", "title": { "ko": "ì„¸í¬ ë°°ì–‘ì•¡", "en": "Conditioned Media" }, "slug": "conditioned-media" }
    ]
  },
  "testimonials": {
    "title": { "ko": "ì—°êµ¬ìë“¤ì˜ í‰ê°€", "en": "What Researchers Say" },
    "items": [
      {
        "quote": {
          "ko": "ì˜¤ë¯¹ìŠ¤AIì˜ ë¨¸ì‹ ëŸ¬ë‹ ëª¨ë¸ì€ ìˆ˜ë™ìœ¼ë¡œëŠ” ì ˆëŒ€ ì°¾ì„ ìˆ˜ ì—†ì—ˆë˜ í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤ ë°ì´í„°ì˜ íŒ¨í„´ì„ ë°œê²¬í–ˆìŠµë‹ˆë‹¤.",
          "en": "OmixAI's machine learning models revealed patterns in our proteomics data we never would have found manually."
        },
        "author": "Dr. Sarah Chen",
        "institution": "MIT"
      },
      {
        "quote": {
          "ko": "ë©€í‹°ì˜¤ë¯¹ìŠ¤ í†µí•© ê¸°ëŠ¥ì€ ì •ë°€ ì˜í•™ ì—°êµ¬ì˜ íŒë„ë¥¼ ë°”ê¾¸ê³  ìˆìŠµë‹ˆë‹¤.",
          "en": "The multi-omics integration capabilities are game-changing for precision medicine research."
        },
        "author": "Dr. Michael Rodriguez",
        "institution": "Stanford University"
      },
      {
        "quote": {
          "ko": "ì˜¤ë¯¹ìŠ¤AIëŠ” ë°”ì´ì˜¤ë§ˆì»¤ ë°œê²¬ ì¼ì •ì„ ìˆ˜ê°œì›” ë‹¨ì¶•ì‹œì¼°ìŠµë‹ˆë‹¤. AI ì¸ì‚¬ì´íŠ¸ëŠ” ë†€ë¼ìš¸ ì •ë„ë¡œ ì •í™•í•©ë‹ˆë‹¤.",
          "en": "OmixAI accelerated our biomarker discovery timeline by months. The AI insights are incredibly accurate."
        },
        "author": "Dr. Emily Watson",
        "institution": "Harvard Medical School"
      }
    ]
  },
  "howItWorks": {
    "title": { "ko": "ì´ìš© ë°©ë²•", "en": "How It Works" },
    "steps": [
      {
        "number": "1",
        "title": { "ko": "ìƒ˜í”Œ ì „ì†¡", "en": "Send Samples" },
        "description": { "ko": "ë¶„ì„ì„ ìœ„í•´ ìƒë¬¼í•™ì  ìƒ˜í”Œì„ ë³´ë‚´ì£¼ì„¸ìš”", "en": "Send us your biological samples for analysis" }
      },
      {
        "number": "2",
        "title": { "ko": "ì§ˆëŸ‰ ë¶„ì„", "en": "Mass Spectrometry" },
        "description": { "ko": "Orbitrap Astralë¡œ ìƒ˜í”Œì„ ë¶„ì„í•©ë‹ˆë‹¤", "en": "We analyze your samples with Orbitrap Astral" }
      },
      {
        "number": "3",
        "title": { "ko": "ì¸ì‚¬ì´íŠ¸ ë¶„ì„", "en": "Insight Analysis" },
        "description": { "ko": "AI ê¸°ë°˜ ë°”ì´ì˜¤ì¸í¬ë§¤í‹±ìŠ¤ë¡œ ë…¼ë¬¸ ì¶œíŒ ê°€ëŠ¥í•œ ê²°ê³¼ë¥¼ ë°›ìœ¼ì„¸ìš”", "en": "Receive publication-ready results with AI-powered bioinformatics" }
      }
    ]
  },
  "footer": {
    "tagline": { "ko": "ë¹ ë¥´ê³ , í¸í–¥ ì—†ëŠ”, ì „ì²´ í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤", "en": "Fast, Unbiased, Whole Proteomics" }
  },
  "resources": {
    "title": { "ko": "ìë£Œ ì„¼í„°", "en": "Resource Center" },
    "subtitle": { "ko": "í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤ ì„œë¹„ìŠ¤ì— ëŒ€í•´ ì•Œì•„ì•¼ í•  ëª¨ë“  ê²ƒ", "en": "Everything you need to know about our proteomics services" },
    "faq": {
      "title": { "ko": "ìì£¼ ë¬»ëŠ” ì§ˆë¬¸", "en": "Frequently Asked Questions" },
      "ordering": {
        "title": { "ko": "ì£¼ë¬¸ ë° ê°€ê²©", "en": "Ordering & Pricing" },
        "items": [
          {
            "question": { "ko": "ì–´ë–»ê²Œ ì£¼ë¬¸í•˜ë‚˜ìš”?", "en": "How do I place an order?" },
            "answer": { "ko": "í”„ë¡œì íŠ¸ ì„¸ë¶€ ì •ë³´ì™€ í•¨ê»˜ omixai@omixai.comìœ¼ë¡œ ë¬¸ì˜í•´ ì£¼ì„¸ìš”. ë§ì¶¤í˜• ê²¬ì ê³¼ ìƒ˜í”Œ ì œì¶œ ì•ˆë‚´ë¥¼ ì œê³µí•´ ë“œë¦½ë‹ˆë‹¤.", "en": "Contact us at omixai@omixai.com with details about your project. We'll provide a customized quote and sample submission instructions." }
          },
          {
            "question": { "ko": "ì¼ë°˜ì ì¸ ì†Œìš” ì‹œê°„ì€ ì–¼ë§ˆë‚˜ ë˜ë‚˜ìš”?", "en": "What is the typical turnaround time?" },
            "answer": { "ko": "í‘œì¤€ í”„ë¡œí…Œì˜¤ë¯¹ìŠ¤ ë¶„ì„ì€ ìƒ˜í”Œ ìˆ˜ë ¹ í›„ 2-4ì£¼ê°€ ì†Œìš”ë©ë‹ˆë‹¤. ê¸´ê¸‰ ì„œë¹„ìŠ¤ë„ ìš”ì²­ ì‹œ ì´ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤.", "en": "Standard proteomics analysis takes 2-4 weeks from sample receipt. Rush services are available upon request." }
          },
          {
            "question": { "ko": "ì–´ë–¤ ê²°ì œ ë°©ë²•ì„ ì‚¬ìš©í•  ìˆ˜ ìˆë‚˜ìš”?", "en": "What payment methods do you accept?" },
            "answer": { "ko": "ê³„ì¢Œ ì´ì²´, í•™ìˆ  ê¸°ê´€ì˜ êµ¬ë§¤ ì£¼ë¬¸ì„œ, ì ê²© ì£¼ë¬¸ì— ëŒ€í•œ ì£¼ìš” ì‹ ìš©ì¹´ë“œë¥¼ ë°›ìŠµë‹ˆë‹¤.", "en": "We accept bank transfers, purchase orders from academic institutions, and major credit cards for qualifying orders." }
          }
        ]
      },
      "samplePrep": {
        "title": { "ko": "ìƒ˜í”Œ ì¤€ë¹„", "en": "Sample Preparation" },
        "items": [
          {
            "question": { "ko": "ì–´ë–¤ ìƒ˜í”Œ ìœ í˜•ì„ ë°›ë‚˜ìš”?", "en": "What sample types do you accept?" },
            "answer": { "ko": "ì„¸í¬, ì¡°ì§, ìƒì²´ì•¡(í˜ˆì¥, í˜ˆì²­, CSF) ë° ë‹¨ë°±ì§ˆ ìš©í•´ë¬¼ì„ ë°›ìŠµë‹ˆë‹¤. íŠ¹ì • ìƒ˜í”Œ ìœ í˜• ìš”êµ¬ ì‚¬í•­ì€ ë¬¸ì˜í•´ ì£¼ì„¸ìš”.", "en": "We accept cells, tissues, biofluids (plasma, serum, CSF), and protein lysates. Contact us for specific sample type requirements." }
          },
          {
            "question": { "ko": "ìƒ˜í”Œ ì–‘ì€ ì–¼ë§ˆë‚˜ í•„ìš”í•œê°€ìš”?", "en": "How much sample material do I need?" },
            "answer": { "ko": "ì¡°ì§: 10-20mg, ì„¸í¬: 100ë§Œ-500ë§Œ ê°œ, í˜ˆì¥/í˜ˆì²­: 10-50Î¼L. ë” ì ì€ ì–‘ë„ ê°€ëŠ¥í•  ìˆ˜ ìˆìœ¼ë‹ˆ ë¬¸ì˜í•´ ì£¼ì„¸ìš”.", "en": "For tissue: 10-20mg, cells: 1-5 million, plasma/serum: 10-50Î¼L. Lower amounts may be possible - please inquire." }
          },
          {
            "question": { "ko": "ìƒ˜í”Œì„ ì–´ë–»ê²Œ ë°°ì†¡í•´ì•¼ í•˜ë‚˜ìš”?", "en": "How should I ship my samples?" },
            "answer": { "ko": "ìµì¼ ë°°ì†¡ íƒë°°ë¡œ ë“œë¼ì´ì•„ì´ìŠ¤ì— ëƒ‰ë™ ìƒ˜í”Œì„ ë°°ì†¡í•´ ì£¼ì„¸ìš”. ì£¼ë¬¸ í™•ì¸ ì‹œ ìì„¸í•œ ë°°ì†¡ ì•ˆë‚´ì™€ ìë£Œë¥¼ ì œê³µí•´ ë“œë¦½ë‹ˆë‹¤.", "en": "Ship frozen samples on dry ice via overnight courier. We'll provide detailed shipping instructions and materials upon order confirmation." }
          },
          {
            "question": { "ko": "ìƒ˜í”Œ í’ˆì§ˆ ìš”êµ¬ ì‚¬í•­ì€ ë¬´ì—‡ì¸ê°€ìš”?", "en": "What are the sample quality requirements?" },
            "answer": { "ko": "ìƒ˜í”Œì€ ê¸‰ì† ëƒ‰ë™ë˜ì–´ -80Â°Cì— ë³´ê´€ë˜ì–´ì•¼ í•©ë‹ˆë‹¤. ë™ê²°-í•´ë™ ì£¼ê¸°ë¥¼ í”¼í•˜ì„¸ìš”. ë¶„ì„ ì§„í–‰ ì „ ìƒ˜í”Œ í’ˆì§ˆì„ í‰ê°€í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.", "en": "Samples should be flash-frozen and stored at -80Â°C. Avoid freeze-thaw cycles. We can assess sample quality before proceeding with analysis." }
          }
        ]
      },
      "technical": {
        "title": { "ko": "ê¸°ìˆ ì  ì„¸ë¶€ ì‚¬í•­", "en": "Technical Details" },
        "items": [
          {
            "question": { "ko": "ì–´ë–¤ ì§ˆëŸ‰ë¶„ì„ í”Œë«í¼ì„ ì‚¬ìš©í•˜ë‚˜ìš”?", "en": "What mass spectrometry platform do you use?" },
            "answer": { "ko": "Thermo Fisher Orbitrap Astralì„ ì‚¬ìš©í•˜ì—¬ ì´ˆê³ í•´ìƒë„(240,000 FWHM)ì™€ ë¯¼ê°ë„ë¡œ ê¹Šì€ í”„ë¡œí…Œì˜´ ì»¤ë²„ë¦¬ì§€ë¥¼ ì œê³µí•©ë‹ˆë‹¤.", "en": "We use the Thermo Fisher Orbitrap Astral, providing ultra-high resolution (240,000 FWHM) and sensitivity for deep proteome coverage." }
          },
          {
            "question": { "ko": "ëª‡ ê°œì˜ ë‹¨ë°±ì§ˆì„ ì‹ë³„í•  ìˆ˜ ìˆë‚˜ìš”?", "en": "How many proteins can you identify?" },
            "answer": { "ko": "ì¸ê°„ ì„¸í¬ì£¼ ë° ì¡°ì§ì—ì„œ ë†’ì€ ì‹ ë¢°ë„(FDR < 1%)ë¡œ 8,000-12,000ê°œì˜ ë‹¨ë°±ì§ˆì„ ì •ê¸°ì ìœ¼ë¡œ ì‹ë³„í•©ë‹ˆë‹¤.", "en": "We routinely identify 8,000-12,000 proteins in human cell lines and tissues with high confidence (FDR < 1%)." }
          },
          {
            "question": { "ko": "ì–´ë–¤ ì •ëŸ‰í™” ë°©ë²•ì„ ì œê³µí•˜ë‚˜ìš”?", "en": "What quantification methods do you offer?" },
            "answer": { "ko": "ì‹¤í—˜ ì„¤ê³„ì— ë”°ë¼ ë¼ë²¨ í”„ë¦¬ ì •ëŸ‰í™”(LFQ), TMT/iTRAQ ë©€í‹°í”Œë ‰ì‹± ë° SILAC ì ‘ê·¼ ë°©ì‹ì„ ì§€ì›í•©ë‹ˆë‹¤.", "en": "We support label-free quantification (LFQ), TMT/iTRAQ multiplexing, and SILAC approaches depending on your experimental design." }
          },
          {
            "question": { "ko": "ì–´ë–¤ ìƒë¬¼ì •ë³´í•™ ë¶„ì„ì´ í¬í•¨ë˜ë‚˜ìš”?", "en": "What bioinformatics analysis is included?" },
            "answer": { "ko": "í‘œì¤€ ë¶„ì„ì—ëŠ” ë‹¨ë°±ì§ˆ ì‹ë³„, ì •ëŸ‰í™”, í†µê³„ í…ŒìŠ¤íŠ¸, GO ë†ì¶• ë° ê²½ë¡œ ë¶„ì„ì´ í¬í•¨ë©ë‹ˆë‹¤. ê³ ê¸‰ AI ê¸°ë°˜ ë¶„ì„ë„ ì´ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤.", "en": "Standard analysis includes protein identification, quantification, statistical testing, GO enrichment, and pathway analysis. Advanced AI-powered analysis is available." }
          }
        ]
      }
    }
  },
  "about": {
    "title": { "ko": "íšŒì‚¬ ì†Œê°œ", "en": "About Us" },
    "subtitle": { "ko": "ê²½ì˜ì§„", "en": "Leadership Team" },
    "team": [
      {
        "name": { "ko": "ì‹ ë™ëª…", "en": "Dongmyeong Shin, Ph.D." },
        "title": "CEO",
        "photo": "/photos/shindongmyeong.jpg",
        "education": {
          "ko": ["2018 ~ 2022     ì„œìš¸ëŒ€í•™êµ Electrical and Computer Engineering Ph. D"],
          "en": ["2018 ~ 2022     Seoul National University, Electrical and Computer Engineering, Ph.D."]
        },
        "experience": {
          "ko": [
            "2025 ~ í˜„ì¬     ì£¼ì‹íšŒì‚¬ ì˜¤ë¯¹ìŠ¤ì—ì´ì•„ì´ ëŒ€í‘œì´ì‚¬",
            "2024 ~ 2025     ì£¼ì‹íšŒì‚¬ ë˜ë””ì„¼ ëŒ€í‘œì´ì‚¬",
            "2021 ~ 2024     ì£¼ì‹íšŒì‚¬ ë˜ë””ì„¼ CTO"
          ],
          "en": [
            "2025 ~ Present     OmixAI Co., Ltd., CEO",
            "2024 ~ 2025     Radisen Co., Ltd., CEO",
            "2021 ~ 2024     Radisen Co., Ltd., CTO"
          ]
        }
      },
      {
        "name": { "ko": "ë°•ì¢…ë°°", "en": "Jong-Bae Park, Ph.D." },
        "title": "CTO",
        "photo": "/photos/parkjongbae.png",
        "education": {
          "ko": ["2002 ~ 2006     Havard Medical School, ë°•ì‚¬í›„ ì—°êµ¬ì›"],
          "en": ["2002 ~ 2006     Harvard Medical School, Postdoctoral Fellow"]
        },
        "experience": {
          "ko": [
            "2025 ~ í˜„ì¬     ì£¼ì‹íšŒì‚¬ ì˜¤ë¯¹ìŠ¤ì—ì´ì•„ì´ CTO",
            "2025 ~ í˜„ì¬     ê²½í¬ëŒ€í•™êµ ì˜ê³¼ëŒ€í•™ ì •êµìˆ˜",
            "2024 ~ í˜„ì¬     í•œêµ­ë‹¨ë°±ìœ ì „ì²´ ì‚¬ë¬´ì´ì¥, ëŒ€í•œì•”í•™íšŒ ì´ì‚¬",
            "2019 ~ 2023     ì‚°í•™í˜‘ë ¥ë‹¨ ë‹¨ì¥",
            "2018 ~ 2021     ì•”ë‹¨ë°±ìœ ì „ì²´ ì—°êµ¬ì‚¬ì—…ë‹¨ ë‹¨ì¥",
            "2018 ~ í˜„ì¬     ì•”ì •ë³µ ì¶”ì§„ ê¸°íšë‹¨ ìœ„ì›",
            "2017 ~ 2021     êµ­ì œì•”ëŒ€í•™ì›ëŒ€í•™êµ ëŒ€í•™ì›ì¥",
            "2014 ~ í˜„ì¬     êµ­ë¦½ì•”ì„¼í„° êµ­ì œì•”ëŒ€í•™ì›ëŒ€í•™ êµìˆ˜",
            "2006 ~ 2014     êµ­ë¦½ì•”ì„¼í„° íŠ¹ìˆ˜ì•”ì—°êµ¬ê³¼ ì±…ì„ì—°êµ¬ì›"
          ],
          "en": [
            "2025 ~ Present     OmixAI Co., Ltd., CTO",
            "2025 ~ Present     Kyung Hee University College of Medicine, Full Professor",
            "2024 ~ Present     Secretary General, Korean Proteome Society; Board Member, Korean Cancer Association",
            "2019 ~ 2023     Director, Industry-Academic Cooperation Foundation",
            "2018 ~ 2021     Director, Cancer Proteomics Research Center",
            "2018 ~ Present     Member, Cancer Control Planning Committee",
            "2017 ~ 2021     Graduate School Dean, National Cancer Center Graduate School of Cancer Science and Policy",
            "2014 ~ Present     Professor, National Cancer Center Graduate School of Cancer Science and Policy",
            "2006 ~ 2014     Principal Investigator, Rare Cancer Research Branch, National Cancer Center"
          ]
        }
      },
      {
        "name": { "ko": "ê¹€ì§„íƒ", "en": "Jin-Taek Kim" },
        "title": "COO",
        "photo": "/photos/kimjintaek.png",
        "education": {
          "ko": ["1995 ~ 1998     êµ­ë¯¼ëŒ€ ë²•ëŒ€ ëŒ€í•™ì› (ìƒë²•ì „ê³µ)"],
          "en": ["1995 ~ 1998     Kookmin University Graduate School of Law (Commercial Law)"]
        },
        "experience": {
          "ko": [
            "2025 ~ í˜„ì¬     ì£¼ì‹íšŒì‚¬ ì˜¤ë¯¹ìŠ¤ì—ì´ì•„ì´ COO",
            "2019 ~ í˜„ì¬     ì£¼ì‹íšŒì‚¬ ì—ì´í”„ë¦´ë°”ì´ì˜¤ CIO",
            "2024 ~ 2025     ì£¼ì‹íšŒì‚¬ ë˜ë””ì„¼ COO",
            "2023 ~ 2024     ì£¼ì‹íšŒì‚¬ ìƒˆë¡¬í•œë°©ì œì•½ ëŒ€í‘œ",
            "2018 ~ 2019     ì£¼ì‹íšŒì‚¬ ê¹ŒìŠ¤í…”ë°”ìŸ‰ ì´ì‚¬",
            "2011 ~ 2018     íŒ¨ì…˜ê·¸ë£¹í˜•ì§€(ì£¼) ê¸°íšì¡°ì •ì‹¤ ì´ì‚¬"
          ],
          "en": [
            "2025 ~ Present     OmixAI Co., Ltd., COO",
            "2019 ~ Present     April Bio Co., Ltd., CIO",
            "2024 ~ 2025     Radisen Co., Ltd., COO",
            "2023 ~ 2024     Saerom Oriental Pharmaceutical, CEO",
            "2018 ~ 2019     Castelbajac, Director",
            "2011 ~ 2018     Fashion Group Hyungji Co., Ltd., Planning & Coordination Office Director"
          ]
        }
      },
      {
        "name": { "ko": "ë°•ê¸°ë°±", "en": "Ki-Baek Park" },
        "title": "CFO",
        "photo": "/photos/parkkibaek.jpg",
        "education": {
          "ko": ["2003 ~ 2007     ìƒí•´ë³µë‹¨ëŒ€í•™êµ (ë²•í•™ í•™ì‚¬)"],
          "en": ["2003 ~ 2007     Fudan University Shanghai (Law)"]
        },
        "experience": {
          "ko": [
            "2025 ~ í˜„ì¬     ì£¼ì‹íšŒì‚¬ ì˜¤ë¯¹ìŠ¤ì—ì´ì•„ì´ CFO",
            "2024 ~ 2025     ì£¼ì‹íšŒì‚¬ ë˜ë””ì„¼ CFO",
            "2020 ~ 2024     ì£¼ì‹íšŒì‚¬ ì˜¨ì½”í¬ë¡œìŠ¤ ì‚¬ì—…ê°œë°œ ì´ì‚¬",
            "2018 ~ 2020     ì£¼ì‹íšŒì‚¬ ì˜¨ì½”í¬ë¡œìŠ¤ CFO",
            "2019 ~ 2021     ì—ìŠ¤ì— ë¹„ë‚˜ ê¸°íšíŒ€ì¥",
            "2016 ~ 2018     ì—ìŠ¤ì— ì‹œë…¸ ê¸°ìˆ íˆ¬ì",
            "2014 ~ 2017     ê¸€ë¡œë²Œë¸Œë¦¿ì§€ ì»¨ì„¤íŒ… ì´ì‚¬",
            "2010 ~ 2013     í™ì½©ê¸€ë¡œë©”ë“œ ê·¸ë£¹ ì´ì‚¬",
            "2007 ~ 2010     í™ì½© ìƒí•´ì¡°í•˜ê²½ê°œë°œêµ¬ ë²¤ì²˜íˆ¬ì"
          ],
          "en": [
            "2025 ~ Present     OmixAI Co., Ltd., CFO",
            "2024 ~ 2025     Radisen Co., Ltd., CFO",
            "2020 ~ 2024     ONCOcross Co., Ltd., Business Development Director",
            "2018 ~ 2020     ONCOcross Co., Ltd., CFO",
            "2019 ~ 2021     SMBina, Planning Team Leader",
            "2016 ~ 2018     SM Sino, Technology Investment",
            "2014 ~ 2017     Global Bridge Consulting, Director",
            "2010 ~ 2013     Hong Kong Glo-Med Group, Director",
            "2007 ~ 2010     Hong Kong Shanghai Development Zone Venture Investment"
          ]
        }
      }
    ],
    "investors": {
      "title": { "ko": "íˆ¬ìì", "en": "Investors" },
      "list": [{ "name": "SM Sino", "logo": "/smsino.png" }]
    },
    "timeline": {
      "title": { "ko": "ì—°í˜", "en": "Timeline" },
      "milestones": [
        { "date": { "ko": "2024. 1", "en": "Jan 2024" }, "event": { "ko": "ëŒ€í•œë¯¼êµ­ ì œ 1í˜¸ Astral ìˆ˜ì…â‹…ì„¤ì¹˜", "en": "First Astral mass spectrometer imported and installed in South Korea" } },
        { "date": { "ko": "2024. 6", "en": "Jun 2024" }, "event": { "ko": "ì£¼ì‹íšŒì‚¬ íŒí…Œë¼ ì„¤ë¦½", "en": "Pantera Inc. founded" } },
        { "date": { "ko": "2024. 6", "en": "Jun 2024" }, "event": { "ko": "ë‹¨ë°±ì²´ ë¶„ì„ ì²« ë§¤ì¶œ", "en": "First proteomics analysis revenue" } },
        { "date": { "ko": "2025. 6", "en": "Jun 2025" }, "event": { "ko": "DIA Proteomics ì „ì²˜ë¦¬ ìë™í™” ë„ì…", "en": "Automated DIA proteomics sample preparation introduced" } },
        { "date": { "ko": "2025. 10", "en": "Oct 2025" }, "event": { "ko": "Radisen AI ì¸ìˆ˜", "en": "Acquired Radisen AI" } },
        { "date": { "ko": "2025. 10", "en": "Oct 2025" }, "event": { "ko": "ë‹¨ë°±ì²´ ë¶„ì„ ì„œë¹„ìŠ¤ ëˆ„ì  ë§¤ì¶œ 6ì–µ", "en": "Cumulative proteomics service revenue reached â‚©600M" } },
        { "date": { "ko": "2025. 11", "en": "Nov 2025" }, "event": { "ko": "LLM ë¶„ì„ í”Œë«í¼ ê°œë°œ ë„ì…", "en": "LLM-powered analysis platform launched" } },
        { "date": { "ko": "2025. 12", "en": "Dec 2025" }, "event": { "ko": "ì˜¨ì½”í¬ë¡œìŠ¤ì™€ ì„œë¹„ìŠ¤ ìš©ì—­ ê³„ì•½ ì²´ê²°", "en": "Service contract signed with OncoCross" } }
      ]
    }
  },
  "contact": {
    "title": { "ko": "ë¬¸ì˜í•˜ê¸°", "en": "Contact Us" },
    "subtitle": { "ko": "ì–¸ì œë“ ì§€ ì—°ë½ ì£¼ì„¸ìš”", "en": "Get in touch with us" },
    "email": {
      "label": { "ko": "ì´ë©”ì¼", "en": "Email" },
      "value": "omixai@omixai.com"
    },
    "phone": {
      "label": { "ko": "ì „í™”", "en": "Phone" },
      "value": "+82-2-1234-5678"
    },
    "kakao": {
      "label": { "ko": "ì¹´ì¹´ì˜¤í†¡", "en": "KakaoTalk" },
      "value": "@omixai"
    },
    "address": {
      "label": { "ko": "ì„œìš¸ ë³¸ì‚¬", "en": "Seoul Headquarters" },
      "value": { "ko": "ì„œìš¸íŠ¹ë³„ì‹œ ë™ëŒ€ë¬¸êµ¬ ì¥í•œë¡œ 43", "en": "5F Gwangseong Building, 43 Janghan-ro" },
      "detail": { "ko": "ê´‘ì„±ë¹Œë”© 5ì¸µ, 02629", "en": "Dongdaemun-gu, Seoul, 02629, South Korea" }
    },
    "map": {
      "title": { "ko": "ì°¾ì•„ì˜¤ì‹œëŠ” ê¸¸", "en": "Location" }
    }
  }
}
